MedTech

HailshadowGettyImages
MedTech

DNA and RNA testing helps identify blood cancer relapse risks

Researchers have found a dual genetic test is more accurate in identifying relapse risks for certain patients with blood cancer.
Ben Adams Oct 13, 2025 10:00am
illustration of the throat

Navidea Biopharmaceuticals files for Chapter 11

Oct 10, 2025 8:10am
Space shuttle takes off on background of blue sky

Shuttle Pharma launches into AI drug discovery via $10M buy

Oct 10, 2025 7:00am
A doctor with a graphic representation of the lungs

Thermo Fisher launches biopsy test to assess lung rejection risk

Oct 9, 2025 10:50am
AZ

Turbine looks to turbocharge AstraZeneca's ADC discovery

Oct 9, 2025 6:00am
blood test

Oxford BioDynamics unveils new target use for EpiSwitch test

Oct 8, 2025 2:34pm